Vujic, Igor
Krankenanstalt Rudolfstiftung der Stadt Wien · Medical University of Vienna
2 papers on CoChatORCID 0000-0003-3013-9823
Most cited papers
- Verified
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Sanlorenzo, M., Vujic, I., Daud, A., Algazi, A., Gubens, M., Luna, S. A., Lin, K., Quaglino, P., Rappersberger, K., & Ortiz-Urda, S. (2015) · JAMA Dermatology
Cancer Immunotherapy and BiomarkersChemotherapy-related skin toxicity
Cited by 449
- Verified
BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD-1 antibody
Sanlorenzo, M., Vujic, I., Floris, A., Novelli, M., Gammaitoni, L., Giraudo, L., Macagno, M., Leuci, V., Rotolo, R., Donini, C., et al. (2018) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways
Cited by 47
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free